Delaying Type 1 Diabetes with Tzield
On November 17, 2022, the FDA approved a new drug that can delay the full onset of type 1 diabetes (T1D). Tzield (teplizumab) — developed by Provention Bio — is truly a “breakthrough therapy” and a huge step forward in the research to prevent and cure T1D. Here’s a closer look at the actual process … Read more